Latest News about Stories That Matter
Recent news which mentions Stories That Matter
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
November 20, 2024
From Benzinga
Target Margins And Inventory Issues Raise Analyst Caution After Weak Q3 Performance
November 20, 2024
From Benzinga
CrowdStrike, Nasdaq, D.R. Horton And More On CNBC's 'Final Trades'
November 20, 2024
From Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
From Benzinga
Microsoft 'One Of The Most Compelling Investment Opportunities,' Says Goldman Sachs
November 20, 2024
From Benzinga
From Benzinga
WeRide's Robotaxi And Partnerships Are Key Growth Drivers For Global Expansion: Analyst
November 20, 2024
From Benzinga
What's Going On With C3.ai Stock Wednesday?
November 20, 2024
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
From Benzinga
Mullen Lands Big Wins With California Universities: Details
November 20, 2024
From Benzinga
4 Reasons Why Ethereum Will Still Outperform Bitcoin—Analyst Sees $4,000 To $6,000 As Target
November 20, 2024
From Benzinga
From Benzinga
Can Baidu Break Bearish Spell? Buying Pressure Shows Bullish Pre-Earnings Potential
November 20, 2024
From Benzinga
What's Going On With Lifeway Stock After Rejecting Revised Acquisition Offer From Danone?
November 20, 2024
From Benzinga
Nvidia Stock Historically Drops In December After Q3 Earnings
November 20, 2024
From Benzinga
Stock Of The Day: Delta Air Lines Bullish Pattern Suggests Upside Ahead
November 20, 2024
Tickers
DAL
From Benzinga
Palantir Tech's $140 Billion Market Cap Gain Is Driven By Trump's Victory And Higher Defense Spending Hope - Is The Stock Overvalued?
November 20, 2024
From Benzinga
From Benzinga
Palo Alto Networks Navigates Bullish Trend, But May Be Ripe For Volatility Ahead Of Earnings
November 20, 2024
From Benzinga
Global-E Soars: Q3 Sales Surge 32%, FY24 Outlook Raised Amid GMV Boom
November 20, 2024
From Benzinga
Snowflake Q3 Earnings: Will Bullish Charts, Analyst Optimism Offset The 32% YTD Decline?
November 20, 2024
From Benzinga
Will Nvidia Deliver A 'Blowout Beat' In Q3? Poll Says Maybe Not, But Over Half See Stock Clearing $150
November 20, 2024
From Benzinga
From Benzinga
What's Going On With GlobalFoundries Stock Today?
November 20, 2024
From Benzinga
Salesforce Tool Aims To Simplify AI Agent Testing, Deployment
November 20, 2024
From Benzinga
From Benzinga
After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
November 20, 2024
From Benzinga
What's Going On With XPeng Stock Today?
November 20, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
